US equities
|
MU
$909.51
▼-0.51%
NVDA
$217.29
▼-1.81%
SNDK
$1,348.31
▼-3.92%
SPCX
$146.36
▼-3.81%
AMD
$546.56
▼-4.25%
INTC
$93.88
▼-4.32%
AAPL
$343.70
▲+0.22%
TSM
$418.25
▼-2.73%
MU
$909.51
▼-0.51%
NVDA
$217.29
▼-1.81%
SNDK
$1,348.31
▼-3.92%
SPCX
$146.36
▼-3.81%
AMD
$546.56
▼-4.25%
INTC
$93.88
▼-4.32%
AAPL
$343.70
▲+0.22%
TSM
$418.25
▼-2.73%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Latest News about Michael Klichinsky
Recent news which mentions Michael Klichinsky
Lab Notes: Arbutus and Penn make headway on Covid-19 treatments; Carisma partners with Merck
December 10, 2021
Tickers
INNO
Tags
Roundup
Kim Smith
The Wistar Institute
From
Business Journals
Lab notes: Incyte gets two FDA approvals, Coriell gets $12.4M research grant, and more
September 24, 2021
Tickers
INNO
Tags
Health Care
Saar Gill
Insurance
From
Business Journals